Syneos Health Inc SYNH

NAS: SYNH | ISIN: US87166B1026   27/09/2023
42,98 USD (+0,02%)
(+0,02%)   27/09/2023

29 april 2024 · Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. · Persbericht

12 april 2024 · Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting · Persbericht

8 april 2024 · Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) · Persbericht

26 september 2023 · Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600 · Persbericht

26 september 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH) · Persbericht

23 september 2023 · SYNEOS 72 HOUR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options · Persbericht

19 september 2023 · SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit · Persbericht

10 september 2023 · Syneos Health, Inc. (SYNH) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds SYNH Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf · Persbericht

5 september 2023 · SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit · Persbericht

2 september 2023 · Kessler Topaz Meltzer & Check, LLP Reminds SYNH Investors of September 25, 2023 Deadline in Securities Fraud Class Action against of Syneos Health, Inc. (SYNH) and Urges Investors with Substantial Losses to Contact the Firm · Persbericht

24 augustus 2023 · Kessler Topaz Meltzer & Check, LLP Reminds Syneos Health, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm · Persbericht

21 augustus 2023 · SYNH Investors Have Opportunity to Lead Syneos Health, Inc. Securities Fraud Lawsuit · Persbericht

14 augustus 2023 · SYNH Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Syneos Health, Inc. (SYNH) Investors of Securities Fraud Class Action Lawsuit · Persbericht

6 augustus 2023 · SYNH CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against SYNH Holdings Limited · Persbericht

1 augustus 2023 · Calling All Syneos Health, Inc. (SYNH) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit! · Persbericht

18 januari 2023 · Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies · Persbericht

2 augustus 2021 · Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization · Persbericht

Mijn selecties